Status:
COMPLETED
Clinical Outcomes of Patients Undergoing Skin-Reducing Mastectomies
Lead Sponsor:
European Institute of Oncology
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-99 years
Brief Summary
The "mastectomy skin reducing" is a surgical procedure involving the removal of the mammary gland and, simultaneously, reducing the excess skin to enhance the aesthetic appearance in breast reconstruc...
Detailed Description
It is a single-center study, conducted exclusively at the European Oncology Institute ( IEO). It is a retrospective study, analyzing events that occurred in the past. The results of this study, aggreg...
Eligibility Criteria
Inclusion
- breast cancer affected women with moderate-large Breast underwent to skin reducing mastectomy.
- High risk breast cancer ( BRCA1 and/or 2 mutated) women with moderate-large Breast underwent to skin reducing mastectomy.
Exclusion
- \-
Key Trial Info
Start Date :
January 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
398 Patients enrolled
Trial Details
Trial ID
NCT06133452
Start Date
January 7 2018
End Date
October 1 2023
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Europeo di Oncologia
Milan, Lombardy, Italy, 20132